These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26822118)
1. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27. Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118 [TBL] [Abstract][Full Text] [Related]
2. In vitro effects of doxorubicin and deracoxib on oxidative-stress-related parameters in canine mammary carcinoma cells. Ustün Alkan F; Bakirel T; Ustüner O; Yardibi H Acta Vet Hung; 2014 Sep; 62(3):372-85. PubMed ID: 25038953 [TBL] [Abstract][Full Text] [Related]
3. The effects of piroxicam and deracoxib on canine mammary tumour cell line. Ustün Alkan F; Ustüner O; Bakırel T; Cınar S; Erten G; Deniz G ScientificWorldJournal; 2012; 2012():976740. PubMed ID: 23251109 [TBL] [Abstract][Full Text] [Related]
4. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition. Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976 [TBL] [Abstract][Full Text] [Related]
5. Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells. Lee R; Lee WY; Park HJ Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732133 [TBL] [Abstract][Full Text] [Related]
6. Response of cultured normal canine mammary epithelial cells to deracoxib-doxorubicin combination. Bakirel T; Ustun Alkan F; Ustuner O; Çinar S; Anlas C; Bilge Sari A Acta Vet Hung; 2017 Sep; 65(3):366-381. PubMed ID: 28956484 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors. Saito T; Tamura D; Asano R Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782 [TBL] [Abstract][Full Text] [Related]
8. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours. Sonzogni-Desautels K; Knapp DW; Sartin E; Doré M Vet Comp Oncol; 2011 Sep; 9(3):161-71. PubMed ID: 21848619 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms. Tamura D; Saito T; Murata K; Kawashima M; Asano R Int J Oncol; 2015 Mar; 46(3):1393-404. PubMed ID: 25571853 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells. Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994 [TBL] [Abstract][Full Text] [Related]
11. Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F. Lin AC; Liao CW; Lin SW; Huang CY; Liou CJ; Lai YS Vet J; 2015 Aug; 205(2):254-62. PubMed ID: 25882637 [TBL] [Abstract][Full Text] [Related]
12. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells. Chen C; Xu W; Wang CM Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119 [TBL] [Abstract][Full Text] [Related]
14. Citrate and celecoxib induce apoptosis and decrease necrosis in synergistic manner in canine mammary tumor cells. Vahidi R; Safi S; Farsinejad A; Panahi N Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):22-8. PubMed ID: 26475384 [TBL] [Abstract][Full Text] [Related]
15. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells. Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287 [TBL] [Abstract][Full Text] [Related]
16. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27. Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783 [TBL] [Abstract][Full Text] [Related]
17. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells. Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line. Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976 [TBL] [Abstract][Full Text] [Related]
20. Methyl Gallate Suppresses Canine Mammary Gland Tumors by Inducing Apoptosis and Anti-angiogenesis. Choi J; Choi JY; Jang H; Jang YJ; Song J; Kim GM; Seol JW Anticancer Res; 2024 Oct; 44(10):4317-4326. PubMed ID: 39348974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]